 comparison sucralfate placebo treatment esophageal ulcers therapeutic endoscopic sclerotherapy esophageal varices prospective randomized trial Roark first report sucralfate treatment esophageal ulcers sclerotherapy uncontrolled trial prospective double-blind placebo-controlled study patients therapeutic paravariceal injection-sclerotherapy esophageal varices patients sucralfate suspension placebo Time treatment maximum weeks dosage sucralfate q.i.d Ulcogant-Suspension endoscopy weekly intervals Fifty-three patients sucralfate placebo evaluable protocol patient study side effects start trial patients sucralfate group ulcer area placebo group tendency sucralfate group patients deeper ulcerations significant difference global healing treatment groups weeks Sucralfate suspension value process esophageal ulcers sclerotherapy patients deep ulcers results trials patients respect ulcer volume severity liver disease